 | Up a level |
Journal Article
Al-Maarri, M., Nickel, N., Roth, A., Hoevelmeyer, N., Hallek, M., Wunderlich, F. T. and Pallasch, C. (2016). AKT ACTIVATION IN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS PROMOTES TRANSFORMATION TOWARDS AGGRESSIVE RICHTER'S SYNDROME LYMPHOMA. Haematologica, 101. S. 10 - 11. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078
Ferreri, A. J. M., Cwynarski, K., Pulczynski, E., Fox, C. P., Schorb, E., La Rosee, P., Binder, M., Fabbri, A., Torri, V., Minacapelli, E., Falautano, M., Ilariucci, F., Ambrosetti, A., Roth, A., Hemmaway, C., Johnson, P., Linton, K. M., Pukrop, T., Gorlov, J. S., Balzarotti, M., Hess, G., Keller, U., Stilgenbauer, S., Panse, J., Tucci, A., Orsucci, L., Pisani, F., Levis, A., Krause, S., Schmoll, H. J., Hertenstein, B., Zaccaria, A., Guarini, A., Atta, J., Bassan, R., Cervetti, J., Elter, T., Enggaard, L., Haenel, M., Kneba, M., Liberati, M., Martelli, M., Martens, U., Morra, E., Pinto, A., Zaja, F., Ponzoni, M., Deckert, M., Politi, L. S., Finke, J., Reni, M., Cavalli, F., Zucca, E. and Illerhaus, G. (2017). Autologous stem cell transplantation (ASCT) or whole-brain radiotherapy (WBRT) as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with newly diagnosed primary cns lymphoma (PCNSL): results of the IELSG32 randomized Phase II Trial. Bone Marrow Transplant., 52. S. S96 - 1. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5365
Nickel, N., Al-Maarri, M., Pal, M., Roth, A., Schaefer, S., Buettner, R., Hallek, M., Wunderlich, T. and Pallasch, C. P. (2016). AKT activation in Chronic Lymphocytic Leukemia cells promotes transformation towards aggressive Richter's syndrome lymphoma. Oncol. Res. Treat., 39. S. 13 - 14. BASEL: KARGER. ISSN 2296-5262
Nickel, N., Roth, A. and Pallasch, C. P. (2015). CHARACTERIZATION OF THE DNA-DAMAGE RESPONSE DOWNSTREAM OF B-CELL RECEPTOR SIGNALING IN CLL. Haematologica, 100. S. 413 - 414. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078